ClinicalTrials.Veeva

Menu
I

IRCCS Centro Neurolesi Bonino Pulejo | Movement and Disorder Section Unit

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

ABBV-951
Foliglurax
Levodopa
PXT002331

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 18 total trials

Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease

Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot fr...

Active, not recruiting
Parkinson's Disease (PD)
Drug: ABBV-951

Trial sponsors

I
AbbVie logo
I
D
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems